The Synuclein-One study is an NIH-funded 30-site multicenter trial that included 50 patients with dementia with Lewy bodies (DLB) and 27 with mild cognitive impairment. Here we report the detection of cutaneous phosphorylated alpha-synuclein (P-SYN) in patients with DLB and MCI.
No takes yet. Share an insight, caveat, or question.
Gibbons et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: